FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000498519> ?p ?o ?g. }

• W2000498519 endingPage "2921" @default.
• W2000498519 startingPage "2919" @default.
• W2000498519 abstract "The central nervous system (CNS) interacts with the periphery to provide feedback regulation during inflammation. The brain and spinal cord sense danger signals released by pathogens outside the CNS and activate wide-ranging defense mechanisms, such as fever and the hypothalamic–pituitary–adrenal axis. Under conditions of autoimmunity the CNS can also modulate somatic responses. For instance, p38 MAP kinase inhibition in the CNS reduces inflammation and bone destruction in rat adjuvant arthritis (1). The spinal mechanisms of this phenomenon have been well delineated (1,2) but the efferent neurologic connections remain poorly characterized.Direct stimulation of the vagus nerve suppresses systemic production of cytokines implicated in arthritis, such as tumor necrosis factor, interleukin-1, and interleukin-6, via a cholinergic antiinflammatory pathway (3). We therefore postulated that spinal p38 engages this pathway. To test this possibility, we used power spectral analysis of heart rate variability to quantify vagal output after intrathecal administration of a p38 inhibitor. The high-frequency power spectral component of heart rate variability (HFP) is a widely used parameter of parasympathetic activity that directly correlates with activation of the cholinergic antiinflammatory pathway (4,5).All animals were handled according to US Department of Agriculture guidelines, and procedures were reviewed and approved by the institutional animal subjects committee. Rats were anesthetized with isoflurane and placed in a supine dorsal recumbent position. Unipolar platinum electrodes were placed onto the anterior chest wall and attached to an amplifier (ECG 100C; Biopac Systems, Santa Barbara, CA). Data were recorded for 70 minutes at a sampling rate of 1 kHz. Power spectral analysis of heart rate variability was calculated using Acqknowledge software (Biopac Systems). After performing fast Fourier transform, the HFP was calculated using a frequency range adapted to the physiologic setting in rats (0.6–1 Hz), to quantify cholinergic outflow.We initially used a cholinesterase inhibitor, galanthamine, to verify that we could detect cholinergic changes in HFP. Vagal efferent fibers augment HFP by releasing acetylcholine, which binds to muscarinic receptors expressed by cardiac pacemaker cells. Acetylcholine is then rapidly converted into inactive metabolites by cholinesterases that can be inhibited with galanthamine. Galanthamine modulates this process by inhibiting acetylcholine esterase and through a central excitatory effect on vagal outflow (5). As shown in Figure 1A, rats treated with galanthamine exhibited significantly increased HFP. The effect of galanthamine on HFP was comparable with the level of vagal stimulation that produces antiinflammatory effects in septic shock models (5). This degree of pharmacologic or electrical vagal stimulation can reduce paw inflammation (6). Galanthamine can mimic the antiinflammatory effects of the vagus nerve, presumably through a combination of increased acetylcholine release and decreased esterase function (3,7).Figure 1A, Systemic administration of the cholinesterase inhibitor galanthamine increases the cholinergic antiinflammatory pathway. The high-frequency component of heart rate variability (HFP), a measure of cholinergic vagal activity, was recorded for 5-minute ...We next evaluated the antiinflammatory effect of galanthamine. Figure 1B shows that the compound significantly reduced swelling in the rat carrageenan paw edema model (6). This observation supports the notion of a potential link between increases in HFP and peripheral antiinflammatory effects, although the relationship between the intensity of cholinergic stimulation in inflamed paws and that in normal cardiac tissue is not known.We then investigated whether p38 within the CNS controls the vagal cholinergic outflow, using the same HFP measurement protocol. Isoflurane-anesthetized Lewis rats (200–250 gm) were implanted with an intrathecal catheter as previously described (2). After a 6-day recovery period, HFP was measured before and after injection of 8 μg of SB203580 through the intrathecal catheter. Intrathecal SB203580 caused a 3-fold rise in HFP that was not observed with intrathecal saline (P < 0.001 by 2-way analysis of variance) (Figure 1C). The increase in cholinergic outflow was noted within 5 minutes and persisted for at least 1 hour after injection. The concentration of SB203580 used has been shown to reduce arthritis after intrathecal administration in the rat adjuvant arthritis model (1). It is a small fraction of the doses typically required to suppress arthritis when given systemically (8), suggesting that the effect is mediated by the CNS. Additional mechanistic studies are needed to determine whether the intensity of acetylcholine receptor stimulation in the synovium correlates with HFP.In conclusion, we found that a very small dose of a p38 inhibitor delivered locally to the intrathecal space increased HFP in the rat. This novel observation demonstrates that MAP kinase signaling within the CNS can potentially activate the cholinergic antiinflammatory pathway. Because vagal stimulation of similar intensity can block inflammation during septic shock (5), this pathway could contribute to the suppression of synovitis after spinal p38 blockade (1). While the peripheral cholinergic mechanisms are still being explored, some studies implicate the alpha7 cholinergic receptor. For instance, acetylcholine can reduce inflammation by stimulating alpha7 receptors on macrophages (7) and can decrease the production of cytokines and chemokines by synoviocytes in vitro (9). If this receptor is confirmed as a key link between the CNS and peripheral inflammation, then selective agonists could have therapeutic utility. Since HFP is a recognized marker of parasympathetic activity in humans (4), our findings using this model suggest that HFP could represent a useful measure in clinical studies of therapies aimed at modulating inflammation via the CNS." @default.
• W2000498519 created "2016-06-24" @default.
• W2000498519 creator A5016490826 @default.
• W2000498519 creator A5017339700 @default.
• W2000498519 creator A5024908446 @default.
• W2000498519 creator A5055960316 @default.
• W2000498519 creator A5069589143 @default.
• W2000498519 creator A5075027868 @default.
• W2000498519 creator A5075492017 @default.
• W2000498519 creator A5078551497 @default.
• W2000498519 date "2008-09-01" @default.
• W2000498519 modified "2023-10-16" @default.
• W2000498519 title "Spinal p38 MAP kinase regulates peripheral cholinergic outflow" @default.
• W2000498519 cites W1973211651 @default.
• W2000498519 cites W1979952002 @default.
• W2000498519 cites W2025689514 @default.
• W2000498519 cites W2069368135 @default.
• W2000498519 cites W2073295417 @default.
• W2000498519 cites W2106447917 @default.
• W2000498519 cites W2160013986 @default.
• W2000498519 cites W2285072859 @default.
• W2000498519 doi "https://doi.org/10.1002/art.23807" @default.
• W2000498519 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4533855" @default.
• W2000498519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18759350" @default.
• W2000498519 hasPublicationYear "2008" @default.
• W2000498519 type Work @default.
• W2000498519 sameAs 2000498519 @default.
• W2000498519 citedByCount "34" @default.
• W2000498519 countsByYear W20004985192012 @default.
• W2000498519 countsByYear W20004985192013 @default.
• W2000498519 countsByYear W20004985192014 @default.
• W2000498519 countsByYear W20004985192015 @default.
• W2000498519 countsByYear W20004985192017 @default.
• W2000498519 countsByYear W20004985192018 @default.
• W2000498519 countsByYear W20004985192019 @default.
• W2000498519 countsByYear W20004985192020 @default.
• W2000498519 countsByYear W20004985192021 @default.
• W2000498519 countsByYear W20004985192022 @default.
• W2000498519 countsByYear W20004985192023 @default.
• W2000498519 crossrefType "journal-article" @default.
• W2000498519 hasAuthorship W2000498519A5016490826 @default.
• W2000498519 hasAuthorship W2000498519A5017339700 @default.
• W2000498519 hasAuthorship W2000498519A5024908446 @default.
• W2000498519 hasAuthorship W2000498519A5055960316 @default.
• W2000498519 hasAuthorship W2000498519A5069589143 @default.
• W2000498519 hasAuthorship W2000498519A5075027868 @default.
• W2000498519 hasAuthorship W2000498519A5075492017 @default.
• W2000498519 hasAuthorship W2000498519A5078551497 @default.
• W2000498519 hasBestOaLocation W20004985191 @default.
• W2000498519 hasConcept C121332964 @default.
• W2000498519 hasConcept C126322002 @default.
• W2000498519 hasConcept C132149769 @default.
• W2000498519 hasConcept C153294291 @default.
• W2000498519 hasConcept C169760540 @default.
• W2000498519 hasConcept C184235292 @default.
• W2000498519 hasConcept C22885893 @default.
• W2000498519 hasConcept C46762472 @default.
• W2000498519 hasConcept C71924100 @default.
• W2000498519 hasConcept C86132830 @default.
• W2000498519 hasConcept C86803240 @default.
• W2000498519 hasConcept C95444343 @default.
• W2000498519 hasConceptScore W2000498519C121332964 @default.
• W2000498519 hasConceptScore W2000498519C126322002 @default.
• W2000498519 hasConceptScore W2000498519C132149769 @default.
• W2000498519 hasConceptScore W2000498519C153294291 @default.
• W2000498519 hasConceptScore W2000498519C169760540 @default.
• W2000498519 hasConceptScore W2000498519C184235292 @default.
• W2000498519 hasConceptScore W2000498519C22885893 @default.
• W2000498519 hasConceptScore W2000498519C46762472 @default.
• W2000498519 hasConceptScore W2000498519C71924100 @default.
• W2000498519 hasConceptScore W2000498519C86132830 @default.
• W2000498519 hasConceptScore W2000498519C86803240 @default.
• W2000498519 hasConceptScore W2000498519C95444343 @default.
• W2000498519 hasIssue "9" @default.
• W2000498519 hasLocation W20004985191 @default.
• W2000498519 hasLocation W20004985192 @default.
• W2000498519 hasLocation W20004985193 @default.
• W2000498519 hasLocation W20004985194 @default.
• W2000498519 hasOpenAccess W2000498519 @default.
• W2000498519 hasPrimaryLocation W20004985191 @default.
• W2000498519 hasRelatedWork W1951208502 @default.
• W2000498519 hasRelatedWork W2005260297 @default.
• W2000498519 hasRelatedWork W2006915175 @default.
• W2000498519 hasRelatedWork W2063812425 @default.
• W2000498519 hasRelatedWork W2123985235 @default.
• W2000498519 hasRelatedWork W2515251450 @default.
• W2000498519 hasRelatedWork W3094184128 @default.
• W2000498519 hasRelatedWork W4321610346 @default.
• W2000498519 hasRelatedWork W4323255813 @default.
• W2000498519 hasRelatedWork W88827397 @default.
• W2000498519 hasVolume "58" @default.
• W2000498519 isParatext "false" @default.
• W2000498519 isRetracted "false" @default.
• W2000498519 magId "2000498519" @default.
• W2000498519 workType "article" @default.